HERBALIFE LTD. Deferred Tax Liabilities, Intangible Assets
HERBALIFE LTD. (HLF) had Deferred Tax Liabilities, Intangible Assets of $69.40 million as of 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets · last filed 2026-02-18
- 2025-12-31: Deferred Tax Liabilities, Intangible Assets $69.40M.
- 2024-12-31: Deferred Tax Liabilities, Intangible Assets $71.90M.
- 2023-12-31: Deferred Tax Liabilities, Intangible Assets $72.70M.
- 2022-12-31: Deferred Tax Liabilities, Intangible Assets $73.00M.
| Period end | Deferred Tax Liabilities, Intangible Assets |
|---|---|
| 2025-12-31 | $69.40M 10-K · filed 2026-02-18 |
| 2024-12-31 | $71.90M 10-K · filed 2026-02-18 |
| 2023-12-31 | $72.70M 10-K · filed 2025-02-19 |
| 2022-12-31 | $73.00M 10-K · filed 2024-02-14 |
| 2021-12-31 | $72.40M 10-K · filed 2023-02-14 |
| 2020-12-31 | $71.20M 10-K · filed 2022-02-23 |
| 2019-12-31 | $71.10M 10-K · filed 2021-02-17 |
| 2018-12-31 | $70.90M 10-K · filed 2020-02-18 |
| 2017-12-31 | $71.10M 10-K · filed 2019-02-19 |
| 2016-12-31 | $112.20M 10-K · filed 2018-02-22 |
| 2015-12-31 | $112.80M 10-K · filed 2017-02-23 |
| 2014-12-31 | $114.20M 10-K · filed 2016-02-25 |
| 2013-12-31 | $113.00M 10-K · filed 2015-02-26 |
| 2012-12-31 | $111.70M 10-K · filed 2014-02-18 |
| 2011-12-31 | $113.10M 10-K/A · filed 2013-12-16 |
| 2010-12-31 | $109.50M 10-K/A · filed 2012-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |